The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.

This includes rimegepant, which is sold by U.S. pharma giant Pfizer under the brand name Vydura, and ubrogepant, sold as ...

AbbVie Inc. closed $6.12 short of its 52-week high ($199.95), which the company reached on September 3rd.

( MENAFN - PR Newswire) ROCKVILLE, Md., Sept. 23, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX ) today announced it will participate in Chardan's 8th Annual Genetic Medicines conference on Monday ...

AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...

After spinning off from Abbott Labs in 2013, biopharmaceutical giant AbbVie had to establish its own culture. Here's how the ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Glaukos (GKOS – Research Report) yesterday and set a price target of $139.00. Ryan ...

Discover the FlexShares Quality Dividend Defensive Index Fund (QDEF) for potential capital gains with limited volatility and ...

AbbVie Inc. closed $6.48 below its 52-week high ($199.95), which the company reached on September 3rd.

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...